Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

TA209 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive

TA209 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive

TA209 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive
27 August 2013
(466.91 Kb 15 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 September 2013